The world has started the transition from an era in which we were utterly helpless about our aging process to one in which aging is under full medical control, and age-related diseases are a thing of the past.
Rejuvenation/Longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse diseases of aging by addressing their common root cause, the aging process itself. Rejuvenation therapies aim to reverse or repair age-related cellular changes such as molecular waste, calcification, tissue stiffening, loss of stem cell function, genetic alterations, and impaired energy production.
The theoretical groundwork has been laid out and scientists are working on the fundamentals. The first generation of therapies is under development at startups around the world, some of them are even available today.
Our goal is to accelerate the development of the young rejuvenation biotech industry and the availability of therapies for human use.